The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2015-09-14
DOI
10.1155/2015/641023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
- (2015) Lorenzo Trippa et al. NEURO-ONCOLOGY
- 11C-MET PET/CT and Advanced MRI in the Evaluation of Tumor Recurrence in High-Grade Gliomas
- (2014) Maria M. D’Souza et al. CLINICAL NUCLEAR MEDICINE
- Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
- (2014) A. Radbruch et al. NEURO-ONCOLOGY
- Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging
- (2014) Oliver T. Wiebenga et al. NMR IN BIOMEDICINE
- Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods
- (2014) James Mountz et al. Cancer Management and Research
- jSIPRO – Analysis tool for magnetic resonance spectroscopic imaging
- (2013) Filip Jiru et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Utility of multiparametric 3-T MRI for glioma characterization
- (2013) Bhaswati Roy et al. NEURORADIOLOGY
- Advanced MR Imaging of Gliomas: An Update
- (2013) Hung-Wen Kao et al. Biomed Research International
- Potential of MR spectroscopy for assessment of glioma grading
- (2012) Martin Bulik et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Quantitative MR imaging and spectroscopy of brain tumours: a step forward?
- (2012) Dita Wagnerova et al. EUROPEAN RADIOLOGY
- Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
- (2011) D.-S. Kong et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
- (2011) L.C. Hygino da Cruz et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results
- (2011) Amr Amin et al. JOURNAL OF NEURO-ONCOLOGY
- Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide
- (2011) M.-Y. C. Polley et al. NEURO-ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Proton Magnetic Resonance Spectroscopy in Differentiating Glioblastomas From Primary Cerebral Lymphomas and Brain Metastases
- (2010) Sanjeev Chawla et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression
- (2009) Elizabeth R. Gerstner et al. JOURNAL OF NEURO-ONCOLOGY
- Differential Diagnosis Between Radiation Necrosis and Glioma Progression Using Sequential Proton Magnetic Resonance Spectroscopy and Methionine Positron Emission Tomography
- (2009) Takeshi NAKAJIMA et al. NEUROLOGIA MEDICO-CHIRURGICA
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
- Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
- (2008) Alba A. Brandes et al. NEURO-ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now